• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets

tetano

Editor, Senior Moderator
Vaccine. 2014 Jun 17. pii: S0264-410X(14)00805-6. doi: 10.1016/j.vaccine.2014.06.016. [Epub ahead of print]
A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets.
Wong SS1, Jeevan T1, Kercher L2, Yoon SW3, Petkova AM1, Crumpton JC1, Franks J1, Debeauchamp J1, Rubrum A1, Seiler P1, Krauss S1, Webster R1, Webby RJ4.
Author information
Abstract

The H7N9 influenza virus caused significant mortality and morbidity in infected humans during an outbreak in China in 2013 stimulating vaccine development efforts. As previous H7-based vaccines have been poorly immunogenic in humans we sought to determine the immunogenic and protective properties of an inactivated whole virus vaccine derived from a 2013 H7N9 virus in ferrets. As whole virus vaccine preparations have been shown to be more immunogenic in humans, but less likely to be used, than split or surface antigen formulations, we vaccinated ferrets with a single dose of 15, 30, or 50μg of the vaccine and subsequently challenged with wild-type A/Anhui/1/2013 (H7N9) either by direct instillation or by contact with infected animals. Although ferrets vaccinated with higher doses of vaccine had higher serum hemagglutinin inhibition (HI) titers, the titers were still low. During subsequent instillation challenge, however, ferrets vaccinated with 50μg of vaccine showed no illness and shed significantly less virus than mock vaccinated controls. All vaccinated ferrets had lower virus loads in their lungs as compared to controls. In a separate study where unvaccinated-infected ferrets were placed in the same cage with vaccinated-uninfected ferrets, vaccination did not prevent infection in the contact ferrets, although they showed a trend of lower viral load. Overall, we conclude that inactivated whole-virus H7N9 vaccine was able to reduce the severity of infection and viral load, despite the lack of hemagglutinin-inhibiting antibodies.

Copyright ? 2014. Published by Elsevier Ltd.
KEYWORDS:

Ferrets; H7N9; Vaccine

PMID:
24950355
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24950355
 
Back
Top Bottom